Cargando…
Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017
In Haiti in 2017, the prevalence of serum vibriocidal antibody titers against Vibrio cholerae serogroup O1 among adults was 12.4% in Cerca-la-Source and 9.54% in Mirebalais, suggesting a high recent prevalence of infection. Improved surveillance programs to monitor cholera and guide public health in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461664/ https://www.ncbi.nlm.nih.gov/pubmed/37610182 http://dx.doi.org/10.3201/eid2909.230401 |
_version_ | 1785097885111549952 |
---|---|
author | Matias, Wilfredo R. Guillaume, Yodeline Augustin, Gertrude Cene Vissieres, Kenia Ternier, Ralph Charles, Richelle C. Harris, Jason B. Franke, Molly F. Ivers, Louise C. |
author_facet | Matias, Wilfredo R. Guillaume, Yodeline Augustin, Gertrude Cene Vissieres, Kenia Ternier, Ralph Charles, Richelle C. Harris, Jason B. Franke, Molly F. Ivers, Louise C. |
author_sort | Matias, Wilfredo R. |
collection | PubMed |
description | In Haiti in 2017, the prevalence of serum vibriocidal antibody titers against Vibrio cholerae serogroup O1 among adults was 12.4% in Cerca-la-Source and 9.54% in Mirebalais, suggesting a high recent prevalence of infection. Improved surveillance programs to monitor cholera and guide public health interventions in Haiti are necessary. |
format | Online Article Text |
id | pubmed-10461664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-104616642023-09-01 Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017 Matias, Wilfredo R. Guillaume, Yodeline Augustin, Gertrude Cene Vissieres, Kenia Ternier, Ralph Charles, Richelle C. Harris, Jason B. Franke, Molly F. Ivers, Louise C. Emerg Infect Dis Dispatch In Haiti in 2017, the prevalence of serum vibriocidal antibody titers against Vibrio cholerae serogroup O1 among adults was 12.4% in Cerca-la-Source and 9.54% in Mirebalais, suggesting a high recent prevalence of infection. Improved surveillance programs to monitor cholera and guide public health interventions in Haiti are necessary. Centers for Disease Control and Prevention 2023-09 /pmc/articles/PMC10461664/ /pubmed/37610182 http://dx.doi.org/10.3201/eid2909.230401 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Dispatch Matias, Wilfredo R. Guillaume, Yodeline Augustin, Gertrude Cene Vissieres, Kenia Ternier, Ralph Charles, Richelle C. Harris, Jason B. Franke, Molly F. Ivers, Louise C. Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017 |
title | Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017 |
title_full | Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017 |
title_fullStr | Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017 |
title_full_unstemmed | Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017 |
title_short | Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017 |
title_sort | seroprevalence of vibrio cholerae in adults, haiti, 2017 |
topic | Dispatch |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461664/ https://www.ncbi.nlm.nih.gov/pubmed/37610182 http://dx.doi.org/10.3201/eid2909.230401 |
work_keys_str_mv | AT matiaswilfredor seroprevalenceofvibriocholeraeinadultshaiti2017 AT guillaumeyodeline seroprevalenceofvibriocholeraeinadultshaiti2017 AT augustingertrudecene seroprevalenceofvibriocholeraeinadultshaiti2017 AT vissiereskenia seroprevalenceofvibriocholeraeinadultshaiti2017 AT ternierralph seroprevalenceofvibriocholeraeinadultshaiti2017 AT charlesrichellec seroprevalenceofvibriocholeraeinadultshaiti2017 AT harrisjasonb seroprevalenceofvibriocholeraeinadultshaiti2017 AT frankemollyf seroprevalenceofvibriocholeraeinadultshaiti2017 AT iverslouisec seroprevalenceofvibriocholeraeinadultshaiti2017 |